Stereotaxis said physicians at the University of Kansas Health System successfully treated the first patients with its ...

Endologix announced final 36-month results for the DETOUR2 study evaluating its Detour system for treating peripheral ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

SimBioSys announced that it received its second FDA 510(k) clearance for TumorSight Viz to expand its use by breast surgeons ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

BlueWind Medical announced that the Centers for Medicare & Medicaid Services (CMS) finalized a favorable payment adjustment ...